Track topics on Twitter Track topics that are important to you
Triumvira Immunologics, an Austin, TX-based biotech, appointed Donna Rill to serve as chief technology officer. Triumvera said Rill will use her technology development and manufacturing experience to ...
The University of Toronto granted Triumvira Immunologics Inc. exclusive rights to antibodies for use in the development of T-cell therapeutics for cancer.
Triumvira Immunologics, a privately held biopharmaceutical company developing a novel platform for engineering T cells to attack cancers, today announced that it will pres...
Innovative immuno-therapy company welcomes former President and COO of Celgene Triumvira Immunologics, Inc., a privately held biopharmaceutical company developin...
Innovative immuno-therapy company welcomes a recognized leader in life sciences and therapeutics Triumvira Immunologics, a privately-held biopharmaceutical company deve...
Brings 30-years of Experience to Company’s Technology Development and Manufacturing Operations Triumvira Immunologics, a privately held biopharmaceutical company deve...
Triumvira Immunologics, Inc., a privately held biopharmaceutical company developing a novel platform for engineering T cells to attack multiple types of cancers, today anno...
The Centre for the Commercialization of Antibodies and Biologics (CCAB) and Triumvira Immunologics, Inc. (Triumvira), announced today a new licensing agreement between the
Triumvira Immunologics, Inc. (âTriumviraâ) is an immunotherapy company co-founded in 2015 by Dr. Jonathan Bramson at McMaster University and Bloom Burton & Co., with the...
Triumvira is developing an engineered T-cell technology called the T-Cell Antigen Coupler (TAC), developed in the laboratory of Dr. Jonathan Bramson at McMaster University in Hami...
Signature Immunologics produces anti-hapten IgGs for High Performance Immunocytochemistry (HPI), targeting key small molecules in cell physiology, including fast neurotransmitter amino acids and pivot...
We have published hundreds of Triumvira Immunologics, Inc. news stories on BioPortfolio along with dozens of Triumvira Immunologics, Inc. Clinical Trials and PubMed Articles about Triumvira Immunologics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Triumvira Immunologics, Inc. Companies in our database. You can also find out about relevant Triumvira Immunologics, Inc. Drugs and Medications on this site too.